Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013
Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First
Quarter ended June 30, 2013 on Tuesday, July 30, 2013 after the Board
Meeting. The results will be available on the Company’s website www.drreddys.com.
|
Summary of Events
|
|
|
|
Event
|
|
|
Date and Time (IST)
|
|
|
Medium
|
|
Release of financial results
|
|
|
July 30th, after the Board Meeting
|
|
|
Email, Media, Company website, Business Wire
|
|
Earnings Call
|
|
|
July 30th, 6.30 PM IST / 9:00 AM EDT
|
|
|
Hosted by the Company
(Details below)
|
|
Webcast of Earnings Call
|
|
|
July 30th, 6.30 PM IST / 9.00 AM EDT through August 4th, 2013
|
|
|
URL available on Company’s website,
www.drreddys.com
|
|
Transcripts of the Earnings call
|
|
|
Will be available on the Company’s website
|
|
|
URL available on Company’s website, www.drreddys.com
|
|
|
|
|
|
|
|
|
Earnings Call
Following the release, the management of the Company will host an
earnings call to discuss the Company’s financial performance.
|
|
|
Conference Dial-In Numbers
|
|
Primary Number:
|
|
|
+91 22 6629 0356
|
|
Secondary Number:
|
|
|
+91 22 3065 0136
|
|
The numbers listed above are universally accessible from all
networks and all countries.
|
|
Local Access Number:
|
|
|
6000 1221
Available in - Ahmedabad, Bangalore,
Bhubaneswar, Chandigarh, Chennai, Coimbatore, Delhi, Goa, Guntur,
Gurgaon, Hyderabad, Indore, Jamshedpur, Kanpur, Kochi/Cochin,
Kolhapur, Kolkata, Nagpur, Noida, Patna, Pune, Raipur, Rajkot,
Surat, Trivandrum, Vadodara, Vijayawada
Accessible from
all major carriers except BSNL/MTNL.
3940 3977
Available
in Ahmedabad, Bangalore, Chandigarh, Chennai, Kochi/Cochin,
Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune
Accessible
from all carriers.
|
|
|
|
|
USA: 1 866 746 2133
|
|
International Toll Free Number:
|
|
|
UK: 0 808 101 1573
|
|
|
|
|
Singapore: 800 101 2045
|
|
|
|
|
Hong Kong: 800 964 448
|
|
|
|
|
|
No password/pin number is necessary to dial in to any of the other
calls. As participation in the call is limited, early registration is
encouraged. The operator will provide instructions on asking questions
before and during the call.
Audio Webcast
The audio webcast of the earnings call will be available to all
interested parties at www.drreddys.com.
Please visit the web site at least fifteen minutes ahead of the
scheduled start time to register and to download and install any
necessary audio software. Participants in the webcast can listen to the
proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through August 4th, 2013. For
play back dial in phone No: 022 3065 1212 and ID: 375#.
Transcript
The transcript of the earnings call will also be available on the
Company's website.
About Dr. Reddy’s
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses –
Pharmaceutical Services and Active Ingredients, Global Generics and
Proprietary Products – Dr. Reddy’s offers a portfolio of products and
services including APIs, custom pharmaceutical services, generics,
biosimilars and differentiated formulations. Major therapeutic focus is
on gastro-intestinal, cardiovascular, diabetology, oncology, pain
management and anti-infective. Major markets include India, USA,
Russia-CIS and Europe apart from other select geographies within
Emerging Markets.
For more information, log on to: www.drreddys.com
*EDT- Eastern Daylight Saving Time
Copyright Business Wire 2013